Ann: Imugene Receives Third PD1-VAXX Ethics Trial Approval, page-16

  1. 3,779 Posts.
    lightbulb Created with Sketch. 8353
    We should also mention that the patents that protect Keytruda and Optdivo can’t protect the owners from PD1 vax.

    PD1 Vax is far cheaper to produce. And we are likely to see much less in the way of mast side effects.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
27.0¢
Change
-0.010(3.57%)
Mkt cap ! $77.89M
Open High Low Value Volume
28.0¢ 28.0¢ 26.5¢ $407.7K 1.508M

Buyers (Bids)

No. Vol. Price($)
30 623451 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 66358 4
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.